{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:42:05Z","timestamp":1771720925490,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.contraception.2008.05.004","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T11:53:26Z","timestamp":1216036406000},"page":"218-225","source":"Crossref","is-referenced-by-count":62,"title":["Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies"],"prefix":"10.1016","volume":"78","author":[{"given":"Jan","family":"Endrikat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Parke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Trummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Duijkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Klipping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.05.004_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/09513599609041268","article-title":"A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene","volume":"10","author":"Dusterberg","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2008.05.004_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.05.004_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0010-7824(97)00123-6","article-title":"Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest","volume":"56","author":"Spona","year":"1997","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2008.05.004_bib4","first-page":"9","article-title":"The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg","volume":"4","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.05.004_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0010-7824(97)00157-1","article-title":"A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low-dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles","volume":"56","author":"Bannemerschult","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(95)00191-C","volume":"52","author":"Endrikat","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/00016348709156490","article-title":"German trial of an oral contraceptive containing 0.150 mg desogestrel plus 0.020 mg ethinylestradiol","volume":"144","author":"Nevinny-Stickel","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2008.05.004_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens","volume":"21","author":"World Health Organization Task Force on Oral Contraception","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.1979.tb11276.x","article-title":"Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol","volume":"86","author":"Astedt","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2008.05.004_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.1.6056.269","article-title":"The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives","volume":"1","author":"Astedt","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2008.05.004_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2008.05.004_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(88)90023-0","article-title":"New natural oestradiol\/cyproterone acetate oral contraceptive for pre-menopausal women","volume":"10","author":"Hirvonen","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2008.05.004_bib13","first-page":"248","article-title":"A multicenter trial with a new OC using a natural estradiol and cyproterone acetate for women over 35","volume":"6","author":"Hirvonen","year":"1990","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2008.05.004_bib14","first-page":"105","article-title":"Alternatives of the replacement of ethinylestradiol by natural 17beta-estradiol in dienogest-containing oral contraceptives","volume":"35","author":"Hoffmann","year":"1999","journal-title":"Drugs Today"},{"key":"10.1016\/j.contraception.2008.05.004_bib15","first-page":"183","article-title":"Efficacy and tolerability of a combined oral contraceptive containing 17 beta-estradiol and desogestrel","volume":"1","author":"Kivinen","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.05.004_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00016348709015732","article-title":"Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel","volume":"66","author":"Schubert","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2008.05.004_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2008.05.004_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0010-7824(96)00201-6","article-title":"The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days","volume":"54","author":"Csemiczky","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.contraception.2008.05.004_bib20","first-page":"517","article-title":"A 19-norprogestin without 17-alpha-ethinyl group II: dienogest from a pharmacodynamic point of view","volume":"31","author":"Oettel","year":"1995","journal-title":"Drugs Today"},{"key":"10.1016\/j.contraception.2008.05.004_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03190010","article-title":"Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study","volume":"24","author":"Timmer","year":"1999","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.contraception.2008.05.004_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/13625180400007736","article-title":"Clinical profile of contraceptive progestins","volume":"9","author":"Benagiano","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2008.05.004_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(03)00556-9","article-title":"Ortho Evra\/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error","volume":"80","author":"Pierson","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2008.05.004_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0010-7824(96)00183-7","article-title":"Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2008.05.004_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2004.03.004","article-title":"Effect of four oral contraceptives on hemostatic parameters","volume":"70","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.05.004_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0038-1646528","article-title":"A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters","volume":"61","author":"Lindberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2008.05.004_bib29","first-page":"1","article-title":"Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects","volume":"107","author":"Helgason","year":"1982","journal-title":"Acta Obstet Gynecol Scand Suppl"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408002886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408002886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T13:00:18Z","timestamp":1557666018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408002886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0010782408002886"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.05.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}